FDA On Use Of AI/ML In Drug Development: Five Key Takeaways | MoFo Life Sciences

On Wednesday, May 10, 2023, the Food and Drug Administration (FDA) announced the publication of a new discussion paper titled “Using Artificial Intelligence and Machine Learning in the Development of Drug and Biological Products.”The discussion paper aims to facilitate a discussion with…

Source: www.jdsupra.com – Read more